Ohcanbohtosat - Naidoo P

  • Čájehuvvo 1 - 3 / 3
Aiddostahte ozu
  1. 1
    Bearbmagovva

    Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study Dahkki Rambiritch V, Maharaj B, Naidoo P

    Almmustuhtton 2014
    Connect to this object online.
    Girji

    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Bearbmagovva

    Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects Dahkki Rambiritch V, Naidoo P, Pillai G

    Almmustuhtton 2016
    Connect to this object online.
    Girji

    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Bearbmagovva

    Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects Dahkki Rambiritch V, Naidoo P, Maharaj B, Pillai G

    Almmustuhtton 2016
    Connect to this object online.
    Girji

    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: